Literature DB >> 28385510

Classical Conditioning Differences Associated With Chronic Pain: A Systematic Review.

Daniel S Harvie1, G Lorimer Moseley2, Susan L Hillier3, Ann Meulders4.   

Abstract

Prominent clinical models of chronic pain propose a fundamental role of classical conditioning in the development of pain-related disability. If classical conditioning is key to this process, then people with chronic pain may show a different response to pain-related conditioned stimuli than healthy control subjects. We set out to determine whether this is the case by undertaking a comprehensive and systematic review of the literature. To identify studies comparing classical conditioning between people with chronic pain and healthy control subjects, the databases MEDLINE, PsychINFO, PsychARTICLES, Scopus, and CINAHL were searched using key words and medical subject headings consistent with 'classical conditioning' and 'pain.' Articles were included when: 1) pain-free control and chronic pain groups were included, and 2) a differential classical conditioning design was used. The systematic search revealed 7 studies investigating differences in classical conditioning between people with chronic pain and healthy control participants. The included studies involved a total of 129 people with chronic pain (fibromyalgia syndrome, spinal pain, hand pain, irritable bowel syndrome), and 104 healthy control participants. Outcomes included indices of pain-related conditioning such as unconditioned stimulus (US) expectancy and contingency awareness, self-report and physiological measures of pain-related fear, evaluative judgements of conditioned stimulus pleasantness, and muscular and cortical responses. Because of variability in outcomes, meta-analyses included a maximum of 4 studies. People with chronic pain tended to show reduced differential learning and flatter generalization gradients with respect to US expectancy and fear-potentiated eyeblink startle responses. Some studies showed a propensity for greater muscular responses and perceptions of unpleasantness in response to pain-associated cues, relative to control cues. PERSPECTIVE: The review revealed preliminary evidence that people with chronic pain may exhibit less differential US expectancy and fear learning. This characteristic may contribute to widespread fear-avoidance behavior. The assumption that altered classical conditioning may be a predisposing or maintaining factor for chronic pain remains to be verified.
Copyright © 2017 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Classical conditioning; associative learning; chronic pain; learning deficits

Mesh:

Year:  2017        PMID: 28385510     DOI: 10.1016/j.jpain.2017.02.430

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  21 in total

1.  Brain Mechanisms of Anticipated Painful Movements and Their Modulation by Manual Therapy in Chronic Low Back Pain.

Authors:  Dan-Mikael Ellingsen; Vitaly Napadow; Ekaterina Protsenko; Ishtiaq Mawla; Matthew H Kowalski; David Swensen; Deanna O'Dwyer-Swensen; Robert R Edwards; Norman Kettner; Marco L Loggia
Journal:  J Pain       Date:  2018-07-03       Impact factor: 5.820

2.  Acceptance-based interoceptive exposure for young children with functional abdominal pain.

Authors:  Nancy Zucker; Christian Mauro; Michelle Craske; H Ryan Wagner; Nandini Datta; Hannah Hopkins; Kristen Caldwell; Adam Kiridly; Samuel Marsan; Gary Maslow; Emeran Mayer; Helen Egger
Journal:  Behav Res Ther       Date:  2017-07-29

3.  Extinction and Renewal of Conditioned Eyeblink Responses in Focal Cerebellar Disease.

Authors:  Katharina M Steiner; Yvonne Gisbertz; Dae-In Chang; Björn Koch; Ellen Uslar; Jens Claassen; Elke Wondzinski; Thomas M Ernst; Sophia L Göricke; Mario Siebler; Dagmar Timmann
Journal:  Cerebellum       Date:  2019-04       Impact factor: 3.847

Review 4.  Association of pain-related threat beliefs and disability with postural control and trunk motion in individuals with low back pain: a systematic review and meta-analysis.

Authors:  Sanaz Shanbehzadeh; Shabnam ShahAli; Isamael Ebrahimi Takamjani; Johan W S Vlaeyen; Reza Salehi; Hassan Jafari
Journal:  Eur Spine J       Date:  2022-05-18       Impact factor: 2.721

5.  Amygdala functional connectivity mediates the association between catastrophizing and threat-safety learning in youth with chronic pain.

Authors:  Inge Timmers; Marina López-Solà; Lauren C Heathcote; Marissa Heirich; Gillian Q Rush; Deborah Shear; David Borsook; Laura E Simons
Journal:  Pain       Date:  2022-04-01       Impact factor: 7.926

Review 6.  Emotion regulation as a transdiagnostic factor underlying co-occurring chronic pain and problematic opioid use.

Authors:  Rachel V Aaron; Patrick H Finan; Stephen T Wegener; Francis J Keefe; Mark A Lumley
Journal:  Am Psychol       Date:  2020-09

Review 7.  The interaction between stress and chronic pain through the lens of threat learning.

Authors:  Inge Timmers; Conny W E M Quaedflieg; Connie Hsu; Lauren C Heathcote; Cynthia R Rovnaghi; Laura E Simons
Journal:  Neurosci Biobehav Rev       Date:  2019-10-14       Impact factor: 8.989

8.  Associative learning and extinction of conditioned threat predictors across sensory modalities.

Authors:  Laura R Koenen; Robert J Pawlik; Adriane Icenhour; Ljubov Petrakova; Katarina Forkmann; Nina Theysohn; Harald Engler; Sigrid Elsenbruch
Journal:  Commun Biol       Date:  2021-05-11

9.  Brain signatures of threat-safety discrimination in adolescent chronic pain.

Authors:  Lauren C Heathcote; Inge Timmers; Corey A Kronman; Farah Mahmud; J Maya Hernandez; Jason Bentley; Andrew M Youssef; Daniel S Pine; David Borsook; Laura E Simons
Journal:  Pain       Date:  2020-03       Impact factor: 7.926

10.  Development and implementation of an inpatient multidisciplinary pain management program for patients with intractable chronic musculoskeletal pain in Japan: preliminary report.

Authors:  Naoto Takahashi; Satoshi Kasahara; Shoji Yabuki
Journal:  J Pain Res       Date:  2018-01-15       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.